SUBSCRIBE
SUBSCRIBE

Test Predicts Novartis AG’s Kinase Inhibitor Resistance in CML, Hokkaido University Study

July 29, 2010 | 
1 min read

MedPage Today -- A novel laboratory test may accurately distinguish which chronic myeloid leukemia (CML) patients will develop resistance to imatinib (Gleevec), researchers said.

Asia
Novartis
MORE ON THIS TOPIC
A pill with the Amercan and Chinese flag wrapped around it
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
June 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Business concept illustration of a businessman digging and mining to find treasure
Antibody-drug conjugate (ADC)
NextCure Joins China-ADC Gold Rush with $745M Simcere Deal
June 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Halftone hands reaching for money. Mixed media catch falling coins and cash bills collage, financial success, free wealth and easy money concept vector illustration
Autoimmune disease
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
June 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Medically accurate illustration of lung cancer. showing presence of cancerous tumor inside the lungs. 3d illustration
Lung Cancer
Summit’s Bispecific Misses Survival Endpoint in Global Phase III Trial but Analysts Remain Optimistic
May 30, 2025
 · 
3 min read
 · 
Nick Paul Taylor